A new study led by UNC researchers that looks at newly diagnosed lung cancer patients and follows them from diagnosis forward is one of the first to give reasons why patients don’t go to lung surgery and why surgery happens less often in blacks.
wonder what this really means
Archive for June, 2010
UNC Study Helps Explain Why Black Patients With Lung Cancer Have Surgery Less Often Than Whites
Saturday, June 26th, 2010Researchers’ Work From Academic Medical Center, Department Of Hematology Focuses On Non-Hodgkin Lymphoma
Saturday, June 26th, 2010A report, ‘Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin’s lymphoma: long-term outcome of the EORTC 20981 phase III randomized intergroup study,’ is newly published data in Journal of Clinical Oncology.
never miss a day, thanks for the blog
Research From University Of Texas, M. D. Anderson Cancer Center In The Area Of Hematology Published
Saturday, June 26th, 2010A report, ‘CT-guided percutaneous lung biopsies in patients with haematologic malignancies and undiagnosed pulmonary lesions,’ is newly published data in Hematological Oncology. According to recent research published in the journal Hematological Oncology, We searched the electronic patient database at The University of Texas M. D. Anderson Cancer Center for patients who underwent computed tomography (CT)-guided needle biopsy between January 2001 and December 2005.
more news brought to your by our blog, thanks for visiting
Study Shows Hodgkin Lymphoma Survivors Lack Post-Treatment Screening For Other Cancers
Saturday, June 26th, 2010A population-based study of 2,071 Hodgkin lymphoma (HL) survivors over 15 years has discovered that while many survivors had multiple X-rays and CT scans years after treatment was finished, they often did not receive recommended cancer screening tests.
check out our ads below, they maybe of interest.
Jevtana Cabazitaxel Injection Approved By U.S. FDA After Priority Review
Saturday, June 26th, 2010Sanofi-aventis announced that the U.S. Food and Drug Administration (FDA) has granted marketing authorization for Jevtana (cabazitaxel) Injection in combination with prednisone for the treatment of patients with metastatic hormone- refractory prostate cancer (mHRPC) previously treated with a docetaxel-containing treatment regimen.
our service is updated everyday, come again
Today’s OpEds: Democrats Can Win With Health Care; States And Medicaid; Rep. Herger On The Cost Of Health Reform
Saturday, June 26th, 2010 Price Tag Of Health Reform Law Too High Roll Call President Barack Obama has acknowledged that our growing national debt is a threat to our future prosperity and that we need fiscal responsibility. Yet instead of using the health care reform debate as an opportunity to put our health care system on a fiscally sustainable path, the president took America in the opposite direction (Rep…
check out our ads below, they maybe of interest.
Medicare To Use New Fraud Identification Tool
Saturday, June 26th, 2010 Gov Info Security: “The Centers for Medicare & Medicaid Services is the first agency to use a new fraud mapping tool that ultimately will be used throughout the federal government…
if people only knew
Few Insurers Control Chunk Of Medicare Advantage Market, Report Finds
Saturday, June 26th, 2010 The Associated Press/Bloomberg BusinessWeek: “A small number of insurers controls a big chunk of the market for Medicare Advantage health plans, according to a new Kaiser Family Foundation report. [KHN is a project of the Kaiser Family Foundation…
health insurance for people with breast cancer
Governors, State Attorneys General Seek To Counter Lawsuit Against Health Law
Saturday, June 26th, 2010 “Gov. Chris Gregoire is joining three fellow Democratic governors in asking a federal judge to consider their opposition to a lawsuit challenging the constitutionality of the nation’s new health-care law,” The Seattle Times reports…
this is so true
Congressional Hearing Explores Medicare Payment Issues, Including Permanent ‘Doc Fix’
Saturday, June 26th, 2010 CongressDaily: A House Energy and Commerce Committee hearing Wednesday ostensibly about a recent Medicare Payment Advisory Commission (MedPAC) report veered to discussion of the so-called “doc fix.” The panel’s chairman, Rep. Frank Pallone, D-N.J…
more to read in our archives